Harmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) price-to-earnings (or "P/E") ratio of 12.6x might make it look like a buy right now compared to the market in the United States, where around half of...
Source LinkHarmony Biosciences Holdings, Inc.'s (NASDAQ:HRMY) price-to-earnings (or "P/E") ratio of 12.6x might make it look like a buy right now compared to the market in the United States, where around half of...
Source Link
Comments